These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 579151)

  • 61. The pulmonary uptake, accumulation, and metabolism of xenobiotics.
    Bend JR; Serabjit-Singh CJ; Philpot RM
    Annu Rev Pharmacol Toxicol; 1985; 25():97-125. PubMed ID: 3890717
    [No Abstract]   [Full Text] [Related]  

  • 62. Drug conjugation in clinical toxicology.
    Prescott LF
    Biochem Soc Trans; 1984 Feb; 12(1):96-9. PubMed ID: 6705998
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Research in the Division of Toxicology. The importance of reactive intermediates of drug biotransformation in drug toxicity.
    Mulder GJ
    Pharm Weekbl Sci; 1985 Apr; 7(2):67-70. PubMed ID: 4000901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhalation pharmacokinetics based on gas uptake studies. I. Improvement of kinetic models.
    Filser JG; Bolt HM
    Arch Toxicol; 1981 Jul; 47(4):279-92. PubMed ID: 7271454
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug elimination interactions: analysis using a mathematical model.
    Luecke RH; Wosilait WD
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):629-41. PubMed ID: 529026
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kinetics of elimination of drugs possessing high affinity for the plasma proteins.
    Martin BK
    Nature; 1965 Aug; 207(5000):959-60. PubMed ID: 5886933
    [No Abstract]   [Full Text] [Related]  

  • 67. Analysis of one-component saturable systems such as ligand binding, enzyme kinetic, uptake, and transport data.
    Zivin JA; Waud DR
    J Pharmacol Methods; 1986 Aug; 16(1):1-22. PubMed ID: 3747543
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DRUG ELIMINATION BY SIMULTANEOUS FIRST-ORDER AND ZERO-ORDER PROCESSES.
    CUMMINGS AJ; MARTIN BK; PARK GS
    Nature; 1964 May; 202():779-80. PubMed ID: 14187617
    [No Abstract]   [Full Text] [Related]  

  • 69. Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics.
    Tsuchiya T; Levy G
    J Pharm Sci; 1972 Apr; 61(4):541-4. PubMed ID: 5014310
    [No Abstract]   [Full Text] [Related]  

  • 70. Free Drug Theory - No Longer Just a Hypothesis?
    Summerfield SG; Yates JWT; Fairman DA
    Pharm Res; 2022 Feb; 39(2):213-222. PubMed ID: 35112229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Toxicity evaluation needs the intact animal.
    Weiss B; Wood RW; Merigan WH
    Ann N Y Acad Sci; 1983; 406():82-91. PubMed ID: 6349468
    [No Abstract]   [Full Text] [Related]  

  • 72. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.
    Vauquelin G; Charlton SJ
    Br J Pharmacol; 2010 Oct; 161(3):488-508. PubMed ID: 20880390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Animal scale-up.
    Dedrick RL
    J Pharmacokinet Biopharm; 1973 Oct; 1(5):435-61. PubMed ID: 4787619
    [No Abstract]   [Full Text] [Related]  

  • 74. Method of obtaining drug-macromolecule binding parameters directly from dynamic dialysis data.
    Pedersen PV; Crooks MJ; Brown KF
    J Pharm Sci; 1977 Oct; 66(10):1458-61. PubMed ID: 925903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of barrier-crossing limitations on the amount of macromolecular drug taken up by its target.
    Aubrée-Lecat A; Duban MC; Demignot S; Domurado M; Fournié P; Domurado D
    J Pharmacokinet Biopharm; 1993 Feb; 21(1):75-98. PubMed ID: 8410684
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preliminary studies on the validity of in vitro measurement of drug toxicity using HeLa cells. II. Drug toxicity in the MIT-24 system compared with mouse and human lethal dosage of 52 drugs.
    Ekwall B
    Toxicol Lett; 1980 Apr; 5(5):309-17. PubMed ID: 7385252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Kinetics of elimination; technics for calculating hemikresis and protorrhea].
    LAPP C
    Prod Pharm; 1956 Mar; 11(3):162-70. PubMed ID: 13323069
    [No Abstract]   [Full Text] [Related]  

  • 78. [Butazolidine inhibition of the enzymatic decomposition of drugs].
    PULVER R
    Arch Int Pharmacodyn Ther; 1954 Aug; 98(4):437-42. PubMed ID: 13208335
    [No Abstract]   [Full Text] [Related]  

  • 79. Illustrations and pharmaceutical interpretations of first order drug elimination rate from the bloodstream.
    SWINTOSKY JV
    J Am Pharm Assoc Am Pharm Assoc; 1956 Jun; 45(6):395-400. PubMed ID: 13319145
    [No Abstract]   [Full Text] [Related]  

  • 80. What can the volume of distribution of a macromolecular drugs indicate?
    Huang JD
    Drug Metab Pharmacokinet; 2010; 25(6):519-20. PubMed ID: 21242645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.